Be Cautious With HBV Drug Withdrawal

More than half of chronic hepatitis B e antigen–negative patients who withdraw from nucleoside or nucleotide analogue therapy experienced relapse within 4 years.

Related Keywords

Taiwan ,Ann Arbor ,Michigan ,United States ,Toronto ,Ontario ,Canada ,America ,American ,Grishma Hirode ,Anna Lok ,University Of Toronto ,University Of Michigan ,North America ,American Association ,Hepatitis B ,Bv Hepatitisb Virus ,Addiction ,Chronic Hepatitis B ,Drug Withdrawal ,Transplantation Liver ,Epatic Transplantation ,Ransplantation Hepatic ,Liver Transplantation ,Insulin Analog ,Insulin Analogue ,Biliary Disease ,Allbladder Disease ,Cirrhosis ,Aminotransferase ,Dust ,Liver Enzymes ,Liver Studies ,Olt ,Europe ,European ,Liver Disease ,Patient Assessment ,Patient Evaluation ,Atient Mo ,